2seventy bio, Inc.
NASDAQ:TSVT
4.72 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 100.387 | 91.496 | 54.522 | 248.122 | 44.296 | 54.579 |
| Cost of Revenue
| 27.203 | 26.219 | 12.588 | 5.396 | 2.978 | 0.885 |
| Gross Profit
| 73.184 | 65.277 | 41.934 | 242.726 | 41.318 | 53.694 |
| Gross Profit Ratio
| 0.729 | 0.713 | 0.769 | 0.978 | 0.933 | 0.984 |
| Reseach & Development Expenses
| 220.473 | 248.735 | 261.937 | 296.467 | 297.645 | 200.49 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 69.414 | 79.45 | 93.506 | 90.897 | 81.646 | 53.631 |
| Other Expenses
| 7.625 | 6.055 | 21.647 | 18.056 | 20.126 | 19.163 |
| Operating Expenses
| 289.887 | 328.185 | 355.443 | 387.364 | 379.291 | 254.121 |
| Operating Income
| -216.703 | -262.908 | -313.509 | -144.638 | -337.973 | -203.426 |
| Operating Income Ratio
| -2.159 | -2.873 | -5.75 | -0.583 | -7.63 | -3.727 |
| Total Other Income Expenses Net
| -0.867 | 8.755 | 21.296 | 24.524 | 17.379 | 16.164 |
| Income Before Tax
| -217.57 | -254.153 | -292.213 | -120.114 | -320.594 | -199.749 |
| Income Before Tax Ratio
| -2.167 | -2.778 | -5.36 | -0.484 | -7.238 | -3.66 |
| Income Tax Expense
| 10.117 | -0.009 | -15.999 | 18.056 | 2.747 | 19.163 |
| Net Income
| -217.57 | -254.144 | -276.214 | -138.17 | -323.341 | -199.749 |
| Net Income Ratio
| -2.167 | -2.778 | -5.066 | -0.557 | -7.3 | -3.66 |
| EPS
| -4.42 | -7.13 | -11.71 | -5.93 | -13.88 | -8.58 |
| EPS Diluted
| -4.42 | -7.13 | -11.71 | -5.93 | -13.88 | -8.58 |
| EBITDA
| -206.418 | -251.143 | -313.07 | -113.394 | -322.639 | -167.919 |
| EBITDA Ratio
| -2.056 | -2.745 | -5.742 | -0.457 | -7.284 | -3.077 |